Treatment of early-stage CTCL

Chalid Assaf, MD, PhD, Helios Klinikum Krefeld, Krefeld, Germany, gives an overview of the treatment of early-stage cutaneous T-cell lymphoma (CTCL), highlighting the use of locally-intensive therapies and commenting on the need to develop therapies which target symptoms. This interview took place at the EORTC Cutaneous Lymphoma Group 20-21 meeting in Marseille.